Kymera Therapeutics Inc (KYMR)

Stock-Based Compensation

$18.94M

Quarterly · Period ending: · USD

KYMR logo

KYMR Stock-Based Compensation

Latest reported$18.94M
KYMR Quarterly Stock-Based Comp ($234.00K → $18.94M)
High-resolution chart · PNG

KYMR stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
18,938,000
16,007,000
14,453,000
15,802,000
15,416,000
14,233,000
13,799,000
14,904,000
14,341,000
11,968,000
10,898,000
11,655,000
11,181,000
9,385,000
8,909,000
9,076,000
9,622,000
7,873,000
8,678,000
7,396,000
5,726,000
3,172,000
1,827,000
2,328,000
664,000
371,000
297,000
234,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.